CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 15 enrolled
Drug / intervention
Magnetic Resonance Imagingdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02470910
NCT02470910N/ACompleted
CompareCT.gov

Incorporating MR Imaging Into Prostate Radiotherapy Treatment Planning: A Pilot Study to Quantitate the Potential to Limit Radiation Dose to Normal Tissues.

Dana-Farber Cancer Institute·interventional·Posted Jun 12, 2015·Updated Dec 11, 2019

In Brief

A clinical study evaluating Magnetic Resonance Imaging for Prostate Cancer and 3 related conditions. Completed, enrolled 15 participants across 1 site.

Detailed Summary

This research study is evaluating whether a standard prostate MRI examination can improve radiation therapy planning for prostate cancer.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsProstate Cancer, Adenocarcinoma of the Prostate Stage I, Adenocarcinoma of the Prostate Stage II, Adenocarcinoma of the Prostate Stage III
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedJun 12, 2015
Enrollment StartJul 1, 2015
Primary CompletionJul 1, 2018
TodayJul 2, 2026
Enrollment to primary: 3 yearsPosted 11.1 years ago

Interventions

Magnetic Resonance Imagingdevice